Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 6
2010 4
2011 8
2012 12
2013 4
2014 10
2015 11
2016 5
2017 6
2018 7
2019 5
2020 6
2021 3
2022 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

78 results
Results by year
Filters applied: . Clear all
Page 1
Abnormal fucosylation of alpha-fetoprotein in patients with nonalcoholic steatohepatitis.
Nouso K, Furubayashi Y, Kariyama K, Wakuta A, Miyake N, Inoue K, Nagai Y, Murakami S, Adachi T, Oyama A, Wada N, Takeuchi Y, Sakata M, Yasunaka T, Onishi H, Shiraha H, Takaki A, Shiota S, Yasuda S, Toyoda H, Kawanaka M, Kumada T, Okada H. Nouso K, et al. Among authors: yasunaka t. Hepatol Res. 2021 May;51(5):548-553. doi: 10.1111/hepr.13626. Epub 2021 Mar 19. Hepatol Res. 2021. PMID: 33596344
Hepatic angiosarcoma with characteristic laparoscopic findings.
Yasunaka T, Ikeda F, Kobashi H, Miyake Y, Takaki A, Iwasaki Y, Hada H, Yamamoto K, Nakano M. Yasunaka T, et al. Dig Endosc. 2012 Mar;24(2):124. doi: 10.1111/j.1443-1661.2011.01171.x. Dig Endosc. 2012. PMID: 22348841 No abstract available.
Monitoring serum proangiogenic cytokines from hepatocellular carcinoma patients treated with sorafenib.
Adachi T, Nouso K, Miyahara K, Oyama A, Wada N, Dohi C, Takeuchi Y, Yasunaka T, Onishi H, Ikeda F, Nakamura S, Shiraha H, Takaki A, Takabatake H, Fujioka SI, Kobashi H, Takuma Y, Iwadou S, Uematsu S, Takaguchi K, Hagihara H, Okada H; Okayama Liver Cancer Group. Adachi T, et al. Among authors: yasunaka t. J Gastroenterol Hepatol. 2019 Jun;34(6):1081-1087. doi: 10.1111/jgh.14535. Epub 2018 Dec 10. J Gastroenterol Hepatol. 2019. PMID: 30402928
A Phase I/Ib trial of Ad-REIC in liver cancer: study protocol.
Oyama A, Shiraha H, Uchida D, Iwamuro M, Kato H, Takaki A, Ikeda F, Onishi H, Yasunaka T, Takeuchi Y, Wada N, Iwasaki Y, Sakata M, Okada H, Kumon H. Oyama A, et al. Among authors: yasunaka t. Future Oncol. 2019 Nov;15(31):3547-3554. doi: 10.2217/fon-2019-0115. Epub 2019 Oct 30. Future Oncol. 2019. PMID: 31663777 Clinical Trial.
Hepatocellular carcinoma occurring in hepatobiliary fibropolycystic disease.
Kinugasa H, Nouso K, Kobayashi Y, Yasunaka T, Onishi H, Nakamura S, Shiraha H, Takayama H, Toshimori J, Kuwaki K, Hagihara H, Miyake Y, Ikeda F, Takaki A, Kobashi H, Yamamoto K. Kinugasa H, et al. Among authors: yasunaka t. Hepatol Res. 2011 Mar;41(3):277-81. doi: 10.1111/j.1872-034X.2010.00761.x. Hepatol Res. 2011. PMID: 21338456
Entecavir Reduces Hepatocarcinogenesis in Chronic Hepatitis B Patients.
Yasunaka T, Ikeda F, Wada N, Morimoto Y, Fujioka S, Toshimori J, Kobashi H, Kariyama K, Morimoto Y, Takayama H, Seno T, Takaguchi K, Moriya A, Miyatake H, Okamoto R, Yabushita K, Takaki A, Yamamoto K. Yasunaka T, et al. Acta Med Okayama. 2016;70(1):1-12. doi: 10.18926/AMO/53996. Acta Med Okayama. 2016. PMID: 26899604 Free article.
78 results